Advertisement
Research Article| Volume 45, ISSUE 7, P1175-1183, May 2009

The abdominoperineal resection itself is associated with an adverse outcome: The European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer

Published:January 07, 2009DOI:https://doi.org/10.1016/j.ejca.2008.11.039

      Abstract

      Purpose

      The aim of this study is to identify factors associated with the decision to perform an abdominoperineal resection (APR) and to assess if these factors or the surgical procedure itself is associated with circumferential resection margin (CRM) involvement, local recurrence (LR), overall survival (OS) and cancer-specific survival (CSS).

      Patients and methods

      The Swedish Rectal Cancer Trial (SRCT), TME trial, CAO/ARO/AIO-94 trial, EORTC 22921 trial and Polish Rectal Cancer Trial (PRCT) were pooled. A propensity score was calculated, which indicated the predicted probability of undergoing an APR given gender, age and distance, and used in the multivariate analyses.

      Results

      An APR procedure was associated with an increased risk of CRM involvement [odd ratio (OR) 2.52, p < 0.001], increased LR rate [hazard ratio (HR) 1.53, p = 0.001] and decreased CSS rate (HR 1.31, p = 0.002), whereas the propensity score was not.

      Conclusion

      The results suggest that the APR procedure itself is a significant predictor for non-radical resections and increased risk of LR and death due to cancer for patients with advanced rectal cancer.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Martijn H.
        • Voogd A.C.
        • van de Poll-Franse L.V.
        • et al.
        Improved survival of patients with rectal cancer since 1980: a population-based study.
        Eur J Cancer. 2003; 39: 2073-2079
        • Madsen P.M.
        • Christiansen J.
        Distal intramural spread of rectal carcinomas.
        Dis Colon Rectum. 1986; 29: 279-282
        • Kapiteijn E.
        • Marijnen C.A.
        • Nagtegaal I.D.
        • et al.
        Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.
        New Engl J Med. 2001; 345: 638-646
        • Peeters K.C.
        • Marijnen C.A.M.
        • Nagtegaal I.D.
        • et al.
        The TME Trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
        Ann Surg. 2007; 246: 693-701
        • Engel A.F.
        • Oomen J.L.
        • Eijsbouts Q.A.
        • Cuesta M.A.
        • van de Velde C.J.H.
        Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial?.
        Colorectal Dis. 2003; 5: 180-184
        • Martling A.L.
        • Holm T.
        • Rutqvist L.E.
        • et al.
        Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.
        Lancet. 2000; 356: 93-96
        • Haward R.A.
        • Morris E.
        • Monson J.R.
        • Johnston C.
        • Forman D.
        The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study.
        Eur J Surg Oncol. 2005; 31: 22-28
        • Marr R.
        • Birbeck K.
        • Garvican J.
        • et al.
        The modern abdominoperineal excision: the next challenge after total mesorectal excision.
        Ann Surg. 2005; 242: 74-82
        • Nagtegaal I.D.
        • van de Velde C.J.H.
        • Marijnen C.A.
        • van Krieken J.H.
        • Quirke P.
        Low rectal cancer: a call for a change of approach in abdominoperineal resection.
        J Clin Oncol. 2005; 23: 9257-9264
        • Påhlman L.
        • Bohe M.
        • Cedermark B.
        • et al.
        The Swedish rectal cancer registry.
        Brit J Surg. 2007; 94: 1285-1292
        • Swedish Rectal Cancer Trial
        Improved survival with preoperative radiotherapy in resectable rectal cancer.
        New Engl J Med. 1997; 336: 980-987
        • Sauer R.
        • Becker H.
        • Hohenberger W.
        • et al.
        Preoperative versus postoperative chemoradiotherapy for rectal cancer.
        New Engl J Med. 2004; 351: 1731-1740
        • Bosset J.F.
        • Collette L.
        • Calais G.
        • et al.
        Chemotherapy with preoperative radiotherapy in rectal cancer.
        New Engl J Med. 2006; 355: 1114-1123
        • Bujko K.
        • Nowacki M.P.
        • Nasierowska-Guttmejer A.
        • et al.
        Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy..
        Radiother Oncol. 2004; 72: 15-24
        • Sobin L.H.
        • Wittekind Ch.
        TNM classification of malignant tumors.
        5th ed. John Wiley & Sons Inc., New York1997
        • Putter H.
        • Fiocco M.
        • Geskus R.B.
        Tutorial in biostatistics: competing risks and multi-state models.
        Stat Med. 2007; 26: 2389-2430
        • Bossema E.R.
        • Stiggelbout A.M.
        • Baas-Thijssen M.C.
        • van de Velde C.J.H.
        • Marijnen C.A.M.
        Patients’ preferences for low rectal cancer surgery.
        Eur J Surg Oncol. 2008; 34: 42-48
        • Quirke P.
        • Sebag-Montefiore D.
        • Steele R.
        • et al.
        Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial.
        J Clin Oncol (Meeting Abstracts). 2006; 24: 3512
        • Holm T.
        • Ljung A.
        • Haggmark T.
        • Jurell G.
        • Lagergren J.
        Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.
        Brit J Surg. 2007; 94: 232-238
        • den Dulk M.
        • Marijnen C.A.
        • Putter H.
        • et al.
        Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
        Ann Surg. 2007; 246: 83-90
        • West N.P.
        • Finan P.J.
        • Anderin C.
        • et al.
        Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer.
        J Clin Oncol. 2008; 26: 3517-3522
        • Bosset J.F.
        • Calais G.
        • Mineur L.
        • et al.
        Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results – EORTC 22921.
        J Clin Oncol. 2005; 23: 5620-5627
        • Marijnen C.A.
        • Nagtegaal I.D.
        • Klein Kranenbarg E.
        • et al.
        No downstaging after short-term preoperative radiotherapy in rectal cancer patients.
        J Clin Oncol. 2001; 19: 1976-1984
        • Radu C.
        • Berglund K.
        • Påhlman L.
        • Glimelius B.
        Short-course preoperative radiotherapy with delayed surgery in rectal cancer – a retrospective study.
        Radiother Oncol. 2008; 87: 343-349
        • Tulchinsky H.
        • Shmueli E.
        • Figer A.
        • Klausner J.M.
        • Rabau M.
        An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
        Ann Surg Oncol. 2008; 15: 2661-2667
        • Bujko K.
        • Nowacki M.P.
        • Nasierowska-Guttmejer A.
        • et al.
        Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
        Brit J Surg. 2006; 93: 1215-1223
        • den Dulk M.
        • Collette L.
        • van de Velde C.J.
        • et al.
        Quality of surgery in T3–4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921.
        Eur J Cancer. 2007; 43: 1821-1828